- June 18, 2013Modern Surgical Technology and the Danger of Operating Room Fire
- June 10, 2013FTC Decision May Reassure Info‐Exchange Participants
- June 3, 2013Using Regression Models to Isolate the Value of a Patented Feature
- May 28, 2013SEC Investigations 101: 20 Frequently Asked Questions
- May 16, 20135 Overlooked Reasons To Be Class Rep In An Antitrust Suit
- May 17, 2013Staying Alive: Appeals and Stays
- May 8, 2013A Trial Lawyers Guide to the New FTC Green Labeling Guidelines
- May 3, 2013Enforcing International Arbitral Awards in U.S. Courts
- May 2013Different Rules, Different Results: Patent Litigation After In re Baxter
- April 24, 2013Why the Auto-Owners v. Second Chance Ruling Is Unique
- April 23, 2013IP: India, Generics and the Impact of Novartis’ Failed Gleevec Claims
- Sunovion Pharma. Inc. v. Teva Pharma. USA, Inc.
- Pfizer Inc. v. Watson Pharma., Inc.
- Allergan, Inc. v. Barr Lab., Inc.
- Senju Pharma. Co. Ltd. v. Apotex, Inc.
- In re Fenofibrate Patent Litig.
- Braintree Labs., Inc. v. Novel Labs., Inc.
- Bristol-Myers Squibb Co. v. Teva Pharma. USA, Inc.
- Spring 2013ANDA Litigation Settlements
- Shire Development LLC. v. Watson Pharma
- Allergan, Inc. v. Apotex, Inc.
- Spring 2013New ANDA Cases
- Generic Launches
- Cephalon, Inc. v. Watson Pharma., Inc. (Fed. Cir.)
- In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation
- Cephalon, Inc. v. Watson Labs., Inc (D.Del.)
- Merck Sharp & Dohme Corp. v. Sandoz Inc.
- Spring 2013ANDA Approvals
- April 12, 2013Cross Appeals
- April 11, 2013Wrongful Death Recoveries in the Era of the Modern Family
- April 9, 2013IP: the Failure of Venue and Joinder Reform in Patent Litigation
- March 18, 2013Using BITs to Protect a Company's Foreign Assets
- April 5, 2013How To Avoid Litigation Before It Begins
- April 3, 2013It All Falls Down
- April 2013Douglas Amdahl
- March 27, 2013Patent Licensing and Assignment with an Eye Toward Enforcement: Tips for University Patent Owners
- March 26, 2013IP: Why Do Patent Cases Cost So Much to Get Through Trial?
- March 18, 2013Split On Calif. Code Upgrade Coverage Remains Unresolved
- March 15, 2013Crossing the t’s and Dotting the i’s
- March 12, 2013IP: Navigating the Divide
- March 7, 2013Will AIA Power Clean Technology?
- March 5, 2013Causation and Anti Concurrent Issues in Connections with Superstorm Sandy
- March 5, 2013Appraisal Issues
- March 2013The Changing Relationship Between Patent Owners and Researchers
- March 1, 20133-D Printing: Strategies to Anticipate the Next Disruptive Technology
- March 1, 2013Risks and Benefits Chiropractic Treatment and the Danger of Stroke
- February 26, 2013IP: Patent Office Trials - A Good Way To Deal With Bad Patents?
- February 22, 2013What Business People Need to Know About Litigation
- February 20, 2013Be Careful With NY Honorable Engagement Provisions
- February 12, 2013IP: 5 Things to Discuss at Your First Case Meeting with Outside Trial Counsel
